The Stevenson Group (TSG) is a global leader in executive search with 40 years’ experience advising clients who are changing the face of healthcare. We partner with life sciences clients ranging from pre-series A start-ups to global, commercial stage companies to build expert executive leadership teams in North America and Europe.
TSG’s sector expertise spans Pharmaceutical, Biotech, Medical Devices/Diagnostics, Healthcare IT and the CRO/CDMO markets. We work broadly appointing executive talent across: research, development, commercial, technical operations/manufacturing, finance, human resources, CEO and Non-Executive Board Members.
TSG has a strong commitment to Diversity & Inclusion with a belief that diversity is critical to creating strong leadership teams and organizations. We are committed to supporting, strengthening and promoting diversity in order to ignite creative thinking based on varied experience. We partner with several D&I industry organizations as a financial sponsor and providing pro bono services to advance this initiative. As a part of TSG’s search process, we measure our diversity efforts internally to ensure we are providing our clients with diverse slates of candidates on every search.
The Stevenson Group was founded by entrepreneur Stephen Steinman in 1979 as a generalist boutique search firm. From 2001 to 2010, TSG evolved into a Life Sciences specialist firm with a pharma, biotech, and technology focus. The 2010 transition from our original founder to a partnership model allowed us to scale our platform for the future and to deepen our footprint in Life Sciences. Since 2010, TSG has tripled the business by expanding existing partnerships and growing new segments geographically and functionally. No longer a boutique, TSG is one of the leading mid-sized executive search firms in Life Sciences.
The Life Sciences industry has the unique responsibility to research, develop, commercialize, and deliver products that have the potential to make a radical difference to millions of patients across the globe. The Stevenson Group considers it a distinct privilege to translate this critical mission into our executive search engagements. Our ultimate success as Life Sciences specialists is determined by the industry impact of the executives we place
Job seekers are becoming more open to opportunities outside their current roles, pointing to a future workforce that is more skilled and more apt to transition into new industries, according to new survey examining the impact of the pandemic on recruiting and job seekers by CareerBuilder. A third of respondents said that too much competition
According to Deloitte’s global sector outlook report on life sciences, persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies as they try to navigate a new world of work – one that requires a dramatic change in strategies for leadership,
As healthcare companies work to stay atop of their drug discovery and development pipelines as well as the competition, it is becoming increasingly apparent that their greatest need is to invest in people, according to Adam Bloom, president of the Stevenson Group, a New Jersey-based executive recruitment firm that specializes in the life sciences. To
As the life sciences sector evolves, this specialized area of executive recruiting is changing as well. For Adam Bloom, president of The Stevenson Group, his expanding role as talent evaluator has elevated in importance due to shifting market forces that have resulted in heightened demand for executives with cross-industry and multi-functional expertise. In the following interview, Mr. Bloom describes the wide
FORT LEE, NJ, July 28, 2016 — The Stevenson Group (TSG) today announced the launch of their new website, which has been redesigned to reflect the significant growth of the firm over the last several years. A mid-sized executive search firm with 37 years in Life Sciences, TSG partners with a broad range of pharmaceutical, biotechnology, medical